bims-smemid Biomed News
on Stress metabolism in mitochondrial dysfunction
Issue of 2026–11–22
three papers selected by
Deepti Mudartha, The International Institute of Molecular Mechanisms and Machines



  1. Sci Adv. 2026 Nov 20. 12(47): eaeg6837
      The perinatal heart undergoes a rapid metabolic transition from glycolysis to fatty acid oxidation that requires extensive mitochondrial remodeling, yet the molecular checkpoints that coordinate this process remain poorly defined. Using temporally resolved proteomics and complexome profiling of developing mouse hearts from late gestation through early postnatal life (E18.5 to P10), we identify a discrete developmental window in which respiratory chain architecture is remodeled to enable metabolic commitment. Complex IV (CIV) emerges as a central structural determinant of this transition, undergoing isoform-specific reassembly and transient suppression at birth before incorporation into mature respiratory supercomplexes. We identify the CIV subunit COX7C as a developmentally regulated determinant of CIV maturation, with its abundance increasing during maximal respirasome assembly and the switch to fatty acid oxidation. Loss of COX7C impairs terminal CIV maturation, prevents incorporation of heart-specific isoforms, and destabilizes the respirasome organization. Notably, this defect causes a selective secondary failure of complex I completion, demonstrating that respirasome formation is required for catalytic CI maturation in vivo. Consequently, cardiac-specific COX7C deficiency fails to complete the perinatal metabolic transition, leading to the collapse of fatty acid oxidation, activation of nucleotide and serine-glycine-one-carbon metabolism, attenuated activation of the mitochondrial integrated stress response, and a metabolically and structurally compromised state unlikely to support the increasing energetic demands of the postnatal heart. Together, these findings define a developmentally timed, CIV-dependent assembly step that couples respiratory chain assembly to postnatal cardiac metabolic fate and provide a temporal framework for mitochondrial maturation in the developing heart.
    DOI:  https://doi.org/10.1126/sciadv.aeg6837
  2. Blood Red Cells Iron. 2026 Sep;2(3): 100091
      Sickle cell disease (SCD) is characterized by chronic hemolysis and excess free heme, which drive oxidative stress, inflammation, and progressive organ damage. Although the pathological consequences of heme are well recognized, its direct impact on erythroid metabolism and epigenetic regulation remains incompletely understood. Here, we demonstrate that excess heme acts as a central metabolic-epigenetic disruptor in sickle erythroblasts, triggering ferroptosis through coordinated suppression of glutamine metabolism and mitochondrial function. Hemin exposure induced robust lipid peroxidation and ferroptotic cell death, accompanied by impaired cystine uptake, glutathione depletion, and increased ferroptosis markers. Mechanistically, heme selectively repressed the catalytically active glutaminase (GLS) isoform GLS type C, leading to reduced intracellular glutamate availability and compromised redox homeostasis. At the epigenetic level, heme promoted global histone hypermethylation and chromatin compaction at genes governing glutamine and glutamate metabolism. This effect was driven by mitochondrial dysfunction and disruption of the oxoglutarate dehydrogenase complex, resulting in the accumulation of l-2-hydroxyglutarate, a potent inhibitor of α-ketoglutarate-dependent histone demethylases. Stable isotope tracing confirmed enhanced glutamine flux toward 2-oxoglutarate and l-2-hydroxyglutarate under heme stress. Importantly, supplementation with the cell-permeable α-ketoglutarate analog dimethyl α-ketoglutarate restored tricarboxylic acid cycle activity, reduced histone hypermethylation, rescued GLS expression, replenished glutathione, and alleviated heme-induced ferroptosis. Together, these findings uncover a previously unrecognized metabolic-epigenetic circuit linking excess heme to mitochondrial dysfunction, chromatin remodeling, and ferroptosis in sickle erythropoiesis and identify metabolic repletion strategies as potential therapeutic treatment approaches for SCD.
    DOI:  https://doi.org/10.1016/j.brci.2026.100091
  3. Adv Sci (Weinh). 2026 Nov 15. pii: e78786. [Epub ahead of print]
      The pathway responsible for mitochondrial [4Fe-4S] cluster assembly plays a crucial role in humans, as evidenced by numerous mitochondrial diseases linked to its dysfunction. GLRX5, FDX2, FDXR, ISCA1, ISCA2, and IBA57 are the proteins involved in the assembly of [4Fe-4S] clusters, but how they cooperate at the molecular level to accomplish this assembly remains unclear. Here, we provide a comprehensive investigation that elucidates the elusive molecular function of IBA57 in mitochondrial [4Fe-4S] cluster assembly. We found that the IBA57 subunit of the [2Fe-2S] IBA57-ISCA2 complex specifically recognizes [2Fe-2S] FDX2 in a transient manner. This interaction enables rapid electron transfer from NADPH to the [2Fe-2S]2+ cluster of the IBA57-ISCA2 complex via the FDXR/FDX2 system, reducing the cluster to [2Fe-2S]+. An NMR data-driven structural model of the transient complex between [2Fe-2S] FDX2 and [2Fe-2S] IBA57-ISCA2 reveals a 17 Å electron transfer pathway connecting the [2Fe-2S] cluster of FDX2 to that of IBA57-ISCA2. Kinetic data showed that [2Fe-2S]+ IBA57-ISCA2, reduced by the NADPH/FDXR/FDX2 system, acts catalytically as an efficient electron donor, promoting reduction of the [2Fe-2S] cluster in the ISCA1-ISCA2 complex. These results highlight the role of IBA57 as an activator of the electron transfer pathway required for the formation of mitochondrial [4Fe-4S] clusters.
    Keywords:  FDX2; IBA57; [4Fe‐4S] cluster biosynthesis; electron transfer; iron‐sulfur protein biogenesis; mitochondria; protein‐protein interaction
    DOI:  https://doi.org/10.1002/advs.78786